Basecamp Vascular
PrivateLast Round
Series A
Dec 12, 2023
Total Funding Raised
$6.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Basecamp Vascular operates in Healthcare & Life Sciences and is based in Reims. Its latest recorded funding round was a Series A round in December 2023.
Basecamp Vascular is a medical device company that develops steerable mechatronic guidewires for endovascular procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Basecamp Vascular Comparables
Compare Basecamp Vascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Artiria Medical | 82% | |
| XCath | 81% | |
| Q'Apel Medical | 80% |
For institutional investors. Book with your work email.
Basecamp Vascular Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Basecamp Vascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forepont Capital Partners | Series A |
| NeuroTechnology Investors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 190% MoM, reaching 1.5K.
- May 14, 2026
Monthly visitors increased 54% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 13, 2026
basecampvascular.com is developing active mechatronic guidewires for controlled access and navigation during minimally invasive endovascular procedures, with physician-controlled, on-demand tip deflection; G0 is an investigational device in development and is not available for sale as of Oct '26.
For institutional investors. Book with your work email.
Basecamp Vascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Basecamp Vascular's valuation, stock price, and market status.
Is Basecamp Vascular a public or private company?
Basecamp Vascular is a private company.
What is the current stock price of Basecamp Vascular?
Basecamp Vascular is a private company, so its shares have no public market price. Caplight tracks Basecamp Vascular's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Basecamp Vascular worth (valuation)?
Valuation information for Basecamp Vascular is not publicly available.
Can I buy Basecamp Vascular stock?
Basecamp Vascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Basecamp Vascular's last funding round?
Basecamp Vascular's most recent funding round was Series A on December 12, 2023.
Who are the main investors in Basecamp Vascular?
Key investors in Basecamp Vascular include Forepont Capital Partners.
Will Basecamp Vascular IPO soon?
No public IPO plans have been announced for Basecamp Vascular.
How can I track Basecamp Vascular secondary market activity?
Caplight tracks bids, offers, and trades in Basecamp Vascular's shares on secondary markets.